Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: Vaccine Therapy in Preventing Cancer Recurrence in Patients With Non-Metastatic, Node Positive, HER2 Negative Breast Cancer That is in Remission [Phase 1]

View source ↗

Summary

This clinical trial update reports results from a Phase 1 study of a cancer vaccine aimed at preventing recurrence in patients with non-metastatic, node-positiv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Washington | Conditions: HER2/Neu Negative, No Evidence of Disease | Phase 1 | Status: COMPLETED | Results posted: 2024-09-19